Efficacy of postoperative mitomycin-C eye drops on the clinical outcome in endoscopic dacryocystorhinostomy

[1]  K. Xue,et al.  Meta-analysis of the Adjunctive Use of Mitomycin C in Primary and Revision, External and Endonasal Dacryocystorhinostomy , 2014, Orbit.

[2]  M. Ali,et al.  Mitomycin C in Dacryocystorhinostomy: The Search for the Right Concentration and Duration—A Fundamental Study on Human Nasal Mucosa Fibroblasts , 2013, Ophthalmic plastic and reconstructive surgery.

[3]  Yan Li,et al.  Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis , 2013, PloS one.

[4]  M. Ali,et al.  Postoperative Application of Mitomycin-C in Endocanalicular Laser Dacryocystorhinostomy , 2012, Ophthalmic plastic and reconstructive surgery.

[5]  J. Rootman,et al.  Stereotactic fractionated radiotherapy for cavernous venous malformations (hemangioma) of the orbit. , 2012, Ophthalmic plastic and reconstructive surgery.

[6]  M. Yazici,et al.  Surgical Outcomes of Primary and Revision Endoscopic Dacryocystorhinostomy , 2010, The Journal of craniofacial surgery.

[7]  S. Leong,et al.  A Systematic Review of Outcomes after Dacryocystorhinostomy in Adults , 2010, American journal of rhinology & allergy.

[8]  E. Aydın,et al.  Comparison of surgical outcomes of endonasal dacryocystorhinostomy with or without mucosal flaps. , 2009, Auris, nasus, larynx.

[9]  R. Pandey,et al.  Topical Mitomycin C as a Postoperative Adjunct to Endonasal Dacryocystorhinostomy in Patients with Anatomical Endonasal Variants , 2009, Orbit.

[10]  V. Yaylalı,et al.  Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy , 2007, International Ophthalmology.

[11]  K. Bhattacharjee,et al.  Effect of mitomycin C on ostium in dacryocystorhinostomy , 2006, Clinical & experimental ophthalmology.

[12]  R. Fechtner,et al.  Antifibrotics and wound healing in glaucoma surgery. , 2003, Survey of ophthalmology.

[13]  F. González del Valle,et al.  [Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid]. , 2002, Archivos de la Sociedad Espanola de Oftalmologia.

[14]  Y. You,et al.  Intraoperative Mitomycin C in Dacryocystorhinostomy , 2001, Ophthalmic plastic and reconstructive surgery.

[15]  D. Oda,et al.  Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. , 2000, Ophthalmic plastic and reconstructive surgery.

[16]  Y. Rozenman,et al.  Treatment of Conjunctival Intraepithelial Neoplasia with Topical Drops of Mitomycin C , 2000, Cornea.

[17]  J. Sugar,et al.  Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. , 1997, Ophthalmology.

[18]  A. Anduze,et al.  Indications for and complications of mitomycin-C in pterygium surgery. , 1996, Ophthalmic surgery and lasers.

[19]  M. Tomasz,et al.  Mitomycin C: small, fast and deadly (but very selective). , 1995, Chemistry & biology.

[20]  C. Foster,et al.  Serious complications of topical mitomycin-C after pterygium surgery. , 1992, Ophthalmology.

[21]  P. Munk,et al.  Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus. , 1990, Radiology.

[22]  A. Berlin,et al.  Dacryocystorhinostomy failure: association with nasolacrimal silicone intubation. , 1989, Ophthalmic surgery.

[23]  H. Levine,et al.  Intranasal Endoscopie Analysis of Dacrocystorhinostomy Failure , 1988, Ophthalmic plastic and reconstructive surgery.

[24]  S. Mccormick,et al.  Primary acquired nasolacrimal duct obstruction. A clinicopathologic report and biopsy technique. , 1986, Ophthalmology.

[25]  J. Flanagan,et al.  Results of dacryocystorhinostomy: analysis of the reoperations. , 1980, Ophthalmic surgery.

[26]  • Epidermis,et al.  WOUND healing. , 1959, The Medical journal of Australia.